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Background: The aim of the present study was to test whether C-Reactive Protein (CRP), a 
proxy measure of inflammation, is elevated in people with higher child and adulthood 
affective symptoms and whether elevated CRP predicts midlife cognitive function. 
Methods: Data were used from the National Child Development Study (n = 6276). Measures 
of memory, verbal fluency, information processing speed and accuracy were available in 
midlife (age 50). Affective symptoms were assessed in childhood (ages 7, 11, 16) and in 
adulthood (ages 23, 33, 42, 50). The level of plasma CRP was measured at age 44. Pathway 
models, unadjusted and fully adjusted for sex, education, childhood socioeconomic position, 
childhood cognitive ability and affective symptoms at age 50, were fitted to test direct 
associations between affective symptoms and midlife cognitive function, and indirect 
associations via the inflammatory pathway (CRP level).  
Results: In a fully adjusted model, there were significant indirect associations between adult 
affective symptoms and immediate memory (β=-0.01, SE=0.003, p=.03) and delayed 
memory (β=-0.01, SE=0.004, p=.03) via CRP. In addition, there were significant indirect 
associations between affective symptoms in childhood and immediate memory (β=-0.001, 
SE=0.00, p=.03) and delayed memory (β=-0.001, SE=0.001, p=.03), via adult affective 
symptoms and associated CRP. Independent of CRP, there was a significant direct 
association between adult affective symptoms and information processing errors (β=0.47, 
SE=0.21, p=.02). There were no direct or indirect associations between affective symptoms 
and verbal fluency or information processing speed. 
Conclusions: CRP at age 44 is elevated in people with higher affective symptoms from age 7 




Systematic reviews have shown that affective symptoms (depression and anxiety) are 
associated with faster cognitive decline and an increased risk of dementia in older adulthood 
(1–6) More recent studies using longitudinal data from British birth cohorts suggest that 
persistent affective symptoms are associated with poorer cognitive function, specifically 
verbal memory in early old age (age 69) (7) and midlife (age 50) (8). Taken together, these 
findings suggest that persistent affective episodes can affect cognitive function as early as 
midlife.  
There is a growing body of research, investigating possible biological mechanisms 
that may contribute to observed associations between affective symptoms and subsequent 
cognitive function. One plausible hypothesis is that inflammation plays an important role in 
the association between affective symptoms and cognition (9–11). Inflammation refers to the 
immune system’s response to threat, such as infection or injury. C-Reactive Protein (CRP) is 
an acute phase reactant, produced in the liver and released into the bloodstream in response to 
inflammation. High concentrations of CRP are indicative of elevated levels of inflammation 
and can therefore be used as an inflammatory marker. There is evidence that peripheral 
measures correlate with inflammatory markers in the brain (12). 
Research has shown a cross-sectional association between depressive symptoms and 
plasma levels of inflammatory markers, including CRP (13, 14). Converging lines of 
evidence support the association between depression and inflammation, whereby elevated 
inflammation can increase vulnerability for depression (15) and psychological stress can 
increase production of pro-inflammatory cytokines (15–18). Additionally, a growing body of 
research has also focussed on the association between depression and CRP over time, 
showing elevated CRP levels in people with cumulative depressive symptoms across 
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adolescence and early adulthood (19). The timing of this longitudinal association remains 
unclear, with research showing that inflammation can precede depression onset and 
contribute to pathogenesis of this condition (20), and also that depressive symptoms are 
associated with elevated fibrinogen (a biomarker of inflammation) across time (21). It is 
therefore possible that associations between inflammation and depression may be 
bidirectional. 
In addition to this, research has proposed that inflammatory changes may be an 
important pathological feature of dementia (9). Specifically, evidence from longitudinal 
studies have shown that peripheral inflammatory markers measured during midlife are 
associated with risk of dementia after 25 years, and that these processes are operating long 
before emergence of clinical symptoms of dementia (12). Systematic reviews have also 
shown that high concentrations of peripheral inflammatory markers are associated with 
increased risk of cognitive impairment and dementia (22, 23). In addition to dementia, 
markers of inflammation including CRP can also prospectively predict poorer cognitive 
function after follow up and faster cognitive decline over time (24). These converging lines 
of evidence suggest that inflammation may play an important role within the association 
between affective symptoms and midlife cognitive function. However, to the best of our 
knowledge this hypothesis has never been directly tested in a prospective population-based 
birth cohort. 
The aim of the present study was therefore to test whether inflammation, measured 
with CRP, is elevated in people with higher affective symptoms over the life course and 
whether elevated CRP is associated with midlife cognitive outcomes. In order to address this 
aim, direct associations of affective symptoms in childhood and adulthood, as well as their 
indirect associations with midlife cognitive function, via the inflammatory pathway were 
estimated. We hypothesised that CRP levels at age 44 will be elevated in people with higher 
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affective symptoms from age 7 to 42, and that elevated CRP levels at age 44 will be 





METHODS AND MATERIALS 
Participants 
Data were used from the National Child Development Study (NCDS), a national 
representative sample of 17,415 people born in England, Scotland and Wales during one 
week of 1958. Data have been collected at ages 0, 7, 11, 16, 23, 33, 42, 44, 46, 50, and 55 
(25). At age 44, biomedical data were collected from a subset of cohort members with 
informed consent (N=9377), and blood samples were drawn. Of the 9,377 people who took 
part in the biomedical sweep, 8,753 consented to blood sample collection. Ethical approval 
for the biomedical sweep at age 44 was provided by the South-East Multi-centre Research 
Ethics Committee. Additional ethical approval for the present study was obtained from the 
University of Sussex (Reference number: ER/AJ316/1). Data can be accessed upon 
application to METADAC.     
Measures 
Cognitive function 
Cognitive data were available at age 50. Short-term and delayed memory were 
assessed using a word recall task consisting of a list of 10 common words recalled 
immediately after presentation and again after a 5-minute delay. Verbal fluency was captured 
by naming as many animals as possible in one minute ((26). Information processing was 
measured using a letter cancellation task, in which participants are required to cross out as 
many target letters (Ps and Ws) as possible within a grid of random letters in one minute. 
Information processing speed is based on the total number of letters searched, and 
information processing accuracy is based on the number of target letters missed up to the last 
letter searched (higher scores represent more errors). These cognitive tasks are described in 




Affective symptoms were assessed repeatedly in childhood and adolescence using the 
Rutter Behaviour Child Scale A at ages 7, 11 and 16. These questionnaires were completed 
by cohort members’ parents, usually the mother. At age 16, the Rutter Behaviour scale 
comprised 18 items, encompassing both internalising and externalising symptoms. At ages 7 
and 11, a shorter version of the Rutter Behaviour scale was administered, comprising 14 
items. According to previous research, at age 16, 5 items from this scale were used to create a 
measure of internalising symptoms (worries, solitary, miserable, fearful, fussy). Four of these 
items were also available at ages 7 and 11 (worries, solitary, miserable, fearful) and these 
were used to create a measure of internalising symptoms at these time-points. These items in 
particular were used in order to be consistent with previous research (28, 29). Confirmatory 
factor analysis (CFA) was used to derive latent scores of affective symptoms at each time-
point. This was a good fit to the data (Supplementary table 1). Mean latent score was also 
calculated across ages 7, 11 and 16 to derive an overall measure of affective symptoms in 
childhood. 
Affective symptoms were assessed repeatedly in adulthood at ages 23, 33, 42, and 50 
using the Malaise Inventory Scale (30). At ages 23, 33, and 42, this was a 24-item self-
completion questionnaire designed to capture psychological distress. At age 50, the short-
form questionnaire (9 items) was used. These 9 items were selected from all four time-points 
to make scores more comparable over time. CFA was conducted on these 9 items at each 
available time-point to derive latent scores of affective symptoms at ages 23, 33, 42, and 50. 
This fitted the data well (Supplementary table 1). Mean latent score was calculated for ages 
23, 33, and 42 and this was used to predict CRP at age 44. The latent affective symptom 




For the purposes of this paper, inflammation status was assessed by recorded level of 
C-Reactive Protein (CRP) in citrated plasma (mg/L), acquired from blood samples collected 
during the biomedical sweep at age 44 by trained nurses and analysed by partnered 
laboratories (Elliott, Johnson, & Shepherd, 2008). CRP was measured on citrated plasma by 
high-sensitivity nephelometric analysis of latex particles which were coated with CRP-
monoclonal antibodies (32). The inter- and intra-assay variation coefficients were > 10% for 
CRP (8.3% and 4.7% respectively). Further details about the processing of CRP data is 
available elsewhere (31). CRP values of >10mg/L (N = 230) are indicative of recent infection 
(33) and as such these cases were excluded from the analysis to be consistent with previous 
research (34, 35). 
Covariables 
Covariables selected for the study were based on previous research and comprised 
measures of sex, educational attainment (36–38), childhood cognition (36, 38–40), and 
childhood socio-economic position (38, 41). Affective symptoms at age 50 were also 
included in the model to account for concurrent affective symptoms. Education was captured 
by cohort member’s highest educational qualification achieved by age 50. This was 
categorised into 1) Low education (up to GCSE level); 2) middle education (up to A Level); 
and 2) high education (Degree). Two measures of childhood cognitive ability (reading and 
mathematics) at age 7 were included. Reading ability was captured using the Southgate 
Group Reading Test, a task designed to assess word recognition and comprehension, 
producing a score ranging from 0-30. Mathematical ability was measured using the Problem 
Arithmetic Test, requiring completion of 10 problem questions, producing a score ranging 
from 0-10. Socio-economic position at age 11 was based on parental occupation and 
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household tenure, categorised into working, intermediate and middle. The derivation of this 
variable was based on guidance from the Centre for Longitudinal Studies (CLS) (Elliott & 
Lawrence, 2014). Specifically, cohort members were coded as middle class if paternal 
occupation was professional, managerial etc (RGSC class I or II) and they were not living in 
council accommodation and mother occupation was not manual. Cohort members were coded 
as intermediate class if paternal occupation was professional/managerial (RGSC class 1 or 2) 
but either the cohort member was living in council accommodation or mother was in a 
manual occupation. Cohort members were also coded as intermediate class in paternal 
occupation was routine non-manual (RGSC clas IIIa). Cohort members were also considered 
to be intermediate class if paternal occupation was manual or in routine service, but they were 
living in accommodation which was owner occupied. Finally, cohort members were coded as 
working class, if paternal occupation was manual or routine service and they were not living 
in accommodation which was owner occupied. 
Analytical procedure 
A series of models were run, estimating the direct associations between childhood and 
adult affective symptoms and cognitive function at age 50. Indirect pathways between 
symptoms and cognitive function through CRP were also estimated. All measures of 
cognitive function were included in the same model to account for covariances between 
different cognitive domains; non-significant covariances were removed from the model. 
Pathway analysis was conducted in Mplus Version 8 (43). 
The initial pathway model was unadjusted, and subsequent models were adjusted for 
sex, education, childhood cognitive ability, childhood socioeconomic position, and affective 
symptoms at age 50. Including sex as a stratifying variable did not significantly improve 
model fit, and as such this was used in all analyses as a covariable (Supplementary Table 2). 
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Model fit was assessed using chi-square goodness of fit, CFI, TLI and RMSEA statistics. All 
missing data were addressed using full information maximum likelihood (FIML) (44–46).  
A sensitivity analysis was conducted to test whether affective symptoms at certain 
ages were more strongly associated with elevated CRP and cognitive outcomes in adulthood. 
In order to do this, the model was re-run using the latent scores of affective symptoms at each 
age as individual predictors in the model. This allows us to identify particular ages at which 
affective symptoms may have important effects on CRP and cognitive outcomes. In addition 
to testing each age as a sensitive period, accumulation was also tested in a further sensitivity 
analysis. Specifically, latent variables of affective symptoms at all ages were dichotomised 
based a cut-off of the 75th percentile, in line with previous research (47). Participants with 
scores lower than the 75th percentile were considered to have no/low symptoms and 
participants with scores higher than 75th percentile were considered to have moderate/high 
affective symptoms. These scores were then summed to create an overall measure of total 
accumulation of affective symptoms from age 7 to 42. The range of possible scores was from 
0 (no time points with moderate/high affective symptoms) to 6 (moderate/high affective 
symptoms at all time points). This method of assessing accumulation has been used in 
previous research using longitudinal birth cohort data (7, 8). The affective symptom 
accumulation score was then added to the model as a predictor. Additionally, the model was 
re-run using the MLR estimator, which is robust to non-normal disrtributions in the model to 
ensure skew did not affect the results. As, results using MLR estimator were substantially 





Missing data and demographic information 
The initial sample was comprised of 9377 participants who took part in the 
biomedical sweep at age 44. Of these 9377 people, 7928 (84.5%) had complete information 
on all cognitive domains. Within the sample with complete cognitive data, 7859 (99.1%) also 
had complete information on affective symptoms. There were 6325 (80.5%) people who also 
had a CRP measure (<10mg/L). Finally, there were 4908 (77.6%) people who also had 
complete covariable data (Figure 1). This final sample did not differ significantly from the 
sample with missing data on sex (p = .94), childhood affective symptoms (p = .08), education 
(p = .09), or childhood socioeconomic position (p = .27). However, the sample with complete 
information showed significantly lower adult affective symptoms (p < .001). Additionally, 
the sample with complete information also had significantly lower CRP levels (p = .02), and 
had significantly higher childhood cognitive scores, based on maths (p = .002) and reading (p 
< .001).  
Additional analysis was conducted to test how missingness on CRP assessment was 
associated with other key observed variables. Cohort members with missing CRP data had 
significantly higher affective symptoms in adulthood (p < .001) and in childhood (p < .001), 
and significantly poorer information processing accuracy scores (p = .01) than cohort 
members with available CRP data. Cohort members with missing CRP data did not 
significantly differ from people with available CRP measures on immediate memory (p = 
.75), delayed memory (p = .054), verbal fluency (p = .96), or information processing 
accuracy (p = .61) scores. The full information maximum likelihood (FIML) method resulted 
in the analytical sample of 6276 participants (see Table 1). 
Direct associations with midlife cognitive function: 
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After adjustment for all key covariables, adult affective symptoms (age 23 to 42) were 
directly associated with information processing accuracy (β = 0.47, SE = 0.21, p = .02) at age 
50, but no other cognitive domains. In this fully adjusted model, there were no significant 
direct associations between childhood affective symptoms and any cognitive domain. There 
were, however, significant direct associations between CRP and immediate memory (β = -
0.04, SE = 0.01, p < .001) and delayed memory (β = -0.05, SE = 0.01, p < .001) at age 50 
(Table 2; Figure 2). 
Indirect associations with midlife cognitive function: 
After adjustment for the covariables, there were significant indirect associations 
between adult affective symptoms on immediate (β = -0.01, SE = 0.003, p = .03) and delayed 
memory (β = -0.01, SE = 0.004, p = .03) at age 50, whereby CRP level was elevated in 
people with higher adult affective symptoms, and this elevated CRP predicted midlife 
memory outcomes. In this fully adjusted model, there were significant indirect associations 
between childhood affective symptoms and information processing accuracy (β = 0.07, SE = 
0.03, p = .03) via adult affective symptoms. Finally, there were significant indirect 
associations between childhood affective symptoms and immediate memory (β = -0.001, SE = 
0.00, p = .03) and delayed memory (β = -0.001, SE = 0.001, p = .03) via adult affective 
symptoms and subsequent CRP level (Table 2; Figure 2). 
Total associations with midlife cognitive function: 
The fully adjusted model showed a significant total association between adult 
affective symptoms and immediate memory (β = -0.22, SE = 0.04, p < .001), delayed 
memory, (β = -0.24, SE = 0.05, p < .001), verbal fluency (β = -0.92, SE = 0.18, p < .001), and 
information processing accuracy (β = 0.55, SE = 0.12, p < .001), but not information 
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processing speed (β = -1.32, SE = 2.58, p = .61). There were no significant total associations 
between childhood affective symptoms and any cognitive domains (Table 2). 
Sensitivity analysis 
Fully adjusted models including latent scores of affective symptoms at each age as 
individual predictors revealed that there were significant direct effects of affective symptoms 
at age 23 on immediate memory (β = -0.07, SE = 0.03, p = .01) and of affective symptoms at 
age 16 (teacher rated) on verbal fluency (β = -0.04, SE = 0.01, p = .002). However, there 
were no significant indirect effects of affective symptoms at any age on cognitive outcomes 
through CRP. 
Sensitivity analysis where models were re-run including scores of accumulation of 
affective symptoms from age 7 through to age 42 showed that there was no significant direct 
associations between accumulation of affective symptoms and any cognitive outcomes. 
However, there were significant indirect associations between accumulation of affective 
symptoms and immediate memory (β = -0.002, SE = 0.001, p = .03) and delayed memory (β 
= -0.002, SE = 0.001, p = .03) at age 50, via CRP. There were no significant indirect 
associations between accumulation of affective symptoms and other cognitive domains 
through CRP. There were significant total effects of accumulation of affective symptoms on 
immediate memory (β = -0.05, SE = 0.01, p < .001), delayed memory (β = -0.05, SE = 0.01, p 
= .001), verbal fluency (β = -0.19, SE = 0.05, p < .001), and information processing accuracy 





Summary of findings & comparison to previous research 
 This study suggests that inflammation may contribute to the link between adult 
affective symptoms and midlife memory. Specifically, CRP levels at age 44 were elevated in 
people with higher adult affective symptoms and elevated CRP was associated with poorer 
immediate and delayed memory at age 50. Similarly, there were significant indirect 
associations between childhood affective symptoms and immediate and delayed 
memory,through adult affective symptoms and CRP level. There was also a direct association 
between adult affective symptoms and information processing accuracy, independent of CRP 
level. There were no significant direct or indirect associations between affective symptoms 
and verbal fluency or information processing speed. Affective symptoms at individual ages 
did not significantly predict CRP and cognitive outcomes. However, the number of time 
points with moderate/high affective symptoms from age 7 to 42 (i.e. accumulation) showed 
significant indirect associations with immediate and delayed memory, via CRP. 
These results support previous research, showing elevated levels of CRP in chronic 
depression (19). Additionally, findings from the current study also support previous research, 
showing that peripheral inflammation levels can be associated with poorer verbal memory 
function in healthy older adults, and that participants with detectable CRP levels had reduced 
medial temporal lobe volume (48). Indeed, other studies have also shown that chronically 
high levels of inflammation in healthy older adults may lead to changes in brain morphology, 
including reduced total grey matter volume (49), white matter integrity (50), and 
hippocampal volume (49). There is also evidence that the effects of inflammation on brain 
structure can be observed during midlife (51–54). Therefore, impaired midlife memory 
function can be a consequence of structural brain changes accompanying chronically elevated 
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inflammation levels. In the current study, the absence of brain imaging data limits 
interrogation of the precise biological mechanism behind the observed associations noted 
here. 
 In contrast to the association between affective symptoms and memory, there were 
only significant direct associations between adult affective symptoms and information 
processing accuracy. No indirect associations were observed between affective symptoms, 
CRP and information processing accuracy. One potential explanation for this may be related 
to the differences in brain structures that the information processing accuracy domain draws 
on compared to memory measures. In addition to this, the inflammation hypothesis is closely 
linked with hippocampal volume change, so this could potentially explain why CRP level 
selectively contributed to the association between affective symptoms and memory measures, 
but not for other cognitive outcomes, including information processing accuracy. 
Additionally, research shows that neuroinflammation disrupts synaptic plasticity (55), and as 
such associations observed for memory exclusively are in line with the literature. It is 
possible that neuroinflammation may be more associated with executive dysfunction or 
processing speed later in the life course. 
Strengths and limitations 
 Key strengths include the use of data from a large prospective birth cohort followed 
up until age 50.  Multiple measures of affective symptoms were available from age 7 through 
age 50, testing the effects of persistent affective symptoms on cognitive function, with a 
follow up period of more than 40 years.  
However, there was only one time point in which measurements of CRP were available in 
this dataset (age 44), meaning that CRP levels from earlier in the life course could not be 
explored. This means that the specific timing and temporal ordering of associations between 
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inflammation and affective symptoms cannot be inferred from this study. Additionally, only 
one single peripheral marker of inflammation (CRP) was used, meaning that caution should 
be used when interpreting these findings, and that results should be confirmed using other 
large longitudinal and prospective cohorts. There was also no brain imaging data available in 
this study and as such the neural mechanisms behind observed associations could not be 
tested. In addition, measures of cognitive function were only available at one time point in 
this dataset (age 50), so cognitive trajectories and rate of decline over time could not be 
modelled in this analysis. An additional limitation is the presence of missing data in the 
study. Attrition is common in long running cohorts; however, in this study it was addressed 
using full information maximum likelihood (FIML). Specifically, the sample with missing 
data showed significantly higher affective symptoms, higher CRP levels, and lower 
childhood cognitive function. Our results may therefore underestimate associations between 
affective symptoms, CRP and cognitive outcomes, because people with more severe affective 
symptoms and poorer childhood cognitive function were less likely to take part. Additionally, 
participants with higher affective symptoms were less likely to have data for CRP available, 
which may have contributed to bias in analyses. 
Future research & conclusions 
These findings show that inflammation may contribute to the observed associations 
between accumulation of affective symptoms and memory function as early as in midlife, a 
period when differences in ageing related cognitive trajectories can first be observed prior to 
the presence of clinical cognitive impairment (56). Results revealed that observed 
associations between adult affective symptoms and information processing accuracy were 
independent of CRP level. Further research is needed to identify the particular biological 
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TABLES AND FIGURE LEGENDS 
Figure 1: Flow chart to show missing data patterns. 
Figure 2: Significant pathways in fully adjusted model. 
Table 1: Demographic information about sample included in fully adjusted model (n = 
6276). 
Table 2: Unadjusted and adjusted models showing direct, indirect and total associations 



















Table 1: Demographic information about sample included in fully adjusted model (n = 
6276). 
Measures 
N (min/max) Mean (SD) (unless 
specified otherwise) 
Immediate memory 8131 (0/10) 6.60 (1.47) 
Delayed memory 8078 (0/10) 5.49 (1.82) 
Verbal fluency 8131 (0/65) 22.54 (6.25) 
Information processing speed 7981 (84/780) 333.21 (87.78) 
Information processing accuracy 7981 (0/48) 4.26 (3.89) 
Child affective symptoms 9292 (-1.00/2.08) 0.03 (0.53) 
Adult affective symptoms 9377 (-0.57/1.72) 0.05 (0.46) 
Age 50 affective symptoms 9377 (-0.61/2.01) 0.07 (0.54) 
CRP level 7462 (0.08/9.96) 1.61 (1.82) 
Sex 
N (%) 
Male  3067 (48.9) 
Female  3209 (51.1) 
Child SEP 
N (%) 
Middle  1356 (21.6) 
Intermediate  2326 (37.1) 
Working  2594 (41.3) 
Childhood cognition 
Reading  24.49 (6.32) 
Arithmetic  5.39 (2.43) 
Education 
N (%) 
Degree level   1626 (25.9) 
Up to A Level  565 (9.0) 
 Up to GCSE Level  4085 (65.1) 
30 
 






Model 1: Unadjusted (N = 9292) 
(X2(1)=10.42, p=.001; CFI=1.00; TLI=0.97; RMSEA=0.03) 





Direct 0.01 (0.03), .83 -0.02 (0.04), .59 -0.02 (0.14), .91 -2.02 (1.98), .31 0.06 (0.09), .53 
Indirect (child AS -> CRP -> cognition) 0.00 (0.002), .90 0.00 (0.003), .90 0.001 (0.01), .90 0.00 (0.01), .93 0.00 (0.001), .90 






-0.01 (0.003), <.001 -0.004 (0.04), .91 0.001 (0.002), .40 
Indirect (child AS -> adult AS -> cognition) -0.05 (0.01), <.001 -0.04, (0.01), <.001 -0.29 (0.03), <.001 0.64 (0.40), .11 0.11 (0.02), <.001 




Direct -0.26 (0.04), <.001 -0.24 (0.05), <.001 -1.61 (0.16), <.001 3.56 (2.22), .11 0.61 (0.10), <.001 
Indirect (adult AS -> CRP -> cognition) -0.02 (0.004), <.001 -0.02 (0.01), <.001 -0.06 (0.02), <.001 -0.02 (0.19), .91 0.01 (0.01), .40 
Total -0.28, (0.04), <.001 -0.26 (0.05), <.001 -1.67 (0.16), <.001 3.53 (2.21), .11 0.62 (0.10), <.001 
Model 2: Fully adjusted (N = 6276)  
(X2(3)= 1.41, p=70; CFI=1.00; TLI=1.00; RMSEA=0.00) 
       






Indirect (child AS -> CRP -> cognition) 0.00 (0.002), .85 0.001 (0.002), .85 0.001 (0.004), .85 -0.01 (0.03), .85 0.00 (0.00), .94 
Indirect (child AS -> adult AS -> cognition) -0.02 (0.01), .16 -0.003 (0.01), .82 -0.06 (0.05), .21 0.63 (0.73), .39 0.07 (0.03), .03 
Indirect (child AS -> adult AS -> CRP -> 
cognition) 
-0.001 (0.00), .03 -0.001 (0.001), .03 -0.002 (0.001), .17 0.01 (0.02), .49 0.00 (0.001), .94 




Direct -0.10 (0.07), .16 -0.02 (0.09), .82 -0.39 (0.31), .21 4.03 (4.63), .39 0.47 (0.21), .02 
Indirect (adult AS -> CRP -> cognition) -0.01 (0.003), .03 -0.01 (0.004), .03 -0.01 (0.01), .17 0.08 (0.11), .49 0.00 (0.01), .94 
Total -0.22 (0.04), <.001 -0.24 (0.05), <.001 -0.92 (0.18), <.001 -1.32 (2.58), .61 0.55 (0.12), <.001 
Sex 0.28 (0.04), <.001 0.47 (0.05), <.001 -0.05 (0.16), .74 25.09 (2.34), <.001 0.24 (0.11), .02 
Education 0.25 (0.02), <.001 0.35 (0.03), <.001 1.26 (0.09), <.001 8.13 (1.39), <.001 0.11 (0.06), .08 
Childhood cognition (maths) 0.06 (0.01), <.001 0.06 (0.01), <.001 0.27 (0.04), <.001 1.12 (0.54), .04 -0.05 (0.02), .05 
Childhood cognition (reading) 0.03 (0.003), <.001 0.04 (0.004), <.001 0.08 (0.01), <.001 0.51 (0.21), .02 -0.04 (0.01), <.001 
Childhood socioeconomic position -0.07 (0.03), <.001 -0.06 (0.03), .06 -0.67 (0.11), <.001 -2.68 (1.55), .08 0.02 (0.07), .83 
Affective symptoms at age 50 -0.11 (0.06), .07 -0.20 (0.08), .01 -0.51 (0.26), .05 -5.34 (3.78), .16 0.08 (0.17), .64 
 









N = 6276; (X2 (1) = 0.98, p = .32; CFI =1.00; TLI = 1.00;  
RMSEA = 0.00) 






Direct -0.01 (0.03), .63 0.01 (0.03), .77 0.04 (0.03), .17 -0.02 (0.03), .57 0.03 (0.03), .34 
Indirect (AS -> CRP -> cognition) 0.003 (0.002), .15 0.003 (0.002), .15 0.001 (0.001), .27 0.00 (0.001), .53 0.00 (0.001), .93 
Total   -0.01 (0.03), .66 0.01 (0.03), .76 0.04 (0.03), .17 -0.02 (0.03), .55 0.03 (0.03), .34 
Age 11 
Direct 0.02 (0.03), .66 -0.01 (0.03), .79 -0.06 (0.03), .08 0.04 (0.04), .32 -0.02 (0.04), .51 
Indirect (AS -> CRP -> cognition) -0.004 (0.002), .06 -0.004 (0.002), .07 -0.002 (0.001), .21 0.001 (0.001), .52 0.00 (0.001), .93 




Direct -0.003 (0.03), .90 -0.01 (0.03), .81 0.03 (0.02), .16 -0.04 (0.03), .09 -0.02 (0.03), .54 
Indirect (AS -> CRP -> cognition) 0.002 (0.002), .15 0.002 (0.002), .15 0.001 (0.001), .28 0.00 (0.001), .53 0.00 (0.001), .93 




Direct -0.02 (0.01), .17 -0.01 (0.01), .37 -0.04 (0.01), .002 -0.01 (0.01), .49 0.02 (0.01), .22 
Indirect (AS -> CRP -> cognition) -0.001 (0.001), .45 -0.001 (0.001), .45 0.00 (0.00), .49 0.00 (0.00), .61 0.00 (0.00), .93 
Total -0.02 (0.01), .16 -0.01 (0.01), .36 -0.04 (0.01), .002 -0.01 (0.01), .50 0.02 (0.01), .22 
Age 23 
Direct -0.07 (0.03), .01 -0.04 (0.03), .17 -0.02 (0.03), .51 0.03 (0.03), .34 -0.02 (0.03), .58 
Indirect (AS -> CRP -> cognition) -0.001 (0.002), .69 -0.001 (0.002), .69 0.00 (0.001), .70 0.00 (0.00), .73 0.0 (0.00), .93 
Total -0.07 (0.03), .01 -0.04 (0.03), .14 -0.02 (0.03), .47 0.03 (0.03), .35 -0.02 (0.03), .58 
Age 33 
Direct 0.03 (0.03), .34 0.03 (0.03), .32 -0.003 (0.03), .94 0.00 (0.04), .99 0.04 (0.04), .23 
Indirect (AS -> CRP -> cognition) -0.002 (0.002), .46 -0.001 (0.002), .46 -0.001 (0.001), .50 0.00 (0.001), .61 0.00 (0.00), .93 
Total 0.03 (0.03), .47 0.02 (0.03), .48 -0.01 (0.03), .79 -0.002 (0.04), .95 0.04 (0.04), .23 
Age 42 Direct 0.01 (0.03), .72 0.004 (0.03), .90 -0.004 (0.03), .90 -0.01 (0.03), .77 0.04 (0.03), .24 
33 
 
Indirect (AS -> CRP -> cognition) 0.001 (0.002), .53 0.001 (0.002), .53 0.00 (0.001), .56 0.00 (0.00), .64 0.00 (0.00), .93 
Total  -0.03 (0.03), .24 -0.05 (0.03), .07 -0.04 (0.03), .11 -0.03 (0.03), .29 0.04 (0.03), .14 
N = 6276; (X2 (2) = 2.61, p = .27; CFI =1.00; TLI = 1.00;  
RMSEA = 0.007) 
       
Accumulation of affective 
symptoms 
Direct -0.02 (0.01), .21 -0.01 (0.01), .62 -0.02 (0.01), .18 -0.02 (0.02), .26 0.003 (0.02), .83 
Indirect (AS -> CRP -> cognition) -0.002 (0.001), .03 -0.002 (0.001), .03 -0.001 (0.001), .17 0.00 (0.001), .47 0.00 (0.001), .94 
Total -0.05 (0.01), <.001 -0.04 (0.01), <.001 -0.05 (0.01), <.001 -0.02 (0.01), .08 0.03 (0.01), .02 
 
Table 3: Adjusted models showing direct, indirect and total associations between affective symptoms at each age and accumulation of affective 
symptoms with mid-life cognitive outcomes 
 
 
 
 
